Previous 10 | Next 10 |
2024-01-24 06:28:18 ET Heron Therapeutics ( NASDAQ: HRTX ) shares rose over 7% premarket on Wednesday after the U.S Food and Drug Administration approved label expansion for the biotechnology company's postoperative pain management solution, Zynrelef (bupivacaine and meloxic...
Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures PR Newswire – Expanded indication for ZYNRELEF now covers approximately 13 million procedures annually – SAN DI...
2024-01-22 06:30:00 ET Company: Heron Therapeutics, Inc. (HRTX) SA Analyst Rating for HRTX: " Buy " SA Quant rating: " Strong Buy ". Seeking FDA Approval for greatly expanded use of ZYNRELEF for post-operative pain management in soft tissue and orthopaedic su...
2024-01-08 06:45:18 ET More on Heron Therapeutics Heron Therapeutics Gets Back On Track Why Heron Therapeutics Is A Compelling Buy Into 2024 Heron Therapeutics, Inc. (HRTX) Q3 2023 Earnings Call Transcript Biggest stock movers today: Boeing, Harpoon Therapeut...
2024-01-08 05:33:37 ET Related stock stories: Boeing: A New Explosive MAX And Stock Crisis? Boeing: The Real Cash Flow Growth Surprise Boeing: $10 Billion FCF Target Appears Realistic By FY25/26, Buy Shares of Boeing and Spirit AeroSystems plunge after mid-ai...
Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain PR Newswire SAN DIEGO , Jan. 7, 2024 /PRNewswire/ -- Heron Th...
2023-12-29 15:14:25 ET Summary HRTX's Zynrelef sales are back on track, with potential for significant growth pending approval of a supplemental New Drug Application. Aponvie sales have been underwhelming thus far and probably won't contribute much to HRTX's revenues in the near t...
2023-11-30 09:00:00 ET Summary Heron Therapeutics develops solutions for pain and discomfort associated with chemotherapy and surgery, with four FDA-approved products. The company underwent a leadership change and implemented a plan to improve efficiency and profitability. Zyn...
2023-11-24 11:48:07 ET Penny stocks are highly speculative equities priced under $5 per share. They grab attention for their rapid rally potential even if the risks give most investors pause. Still, short-term traders look for volatile penny stock picks for explosive upside moves, espec...
2023-11-20 11:35:20 ET More on Heron Therapeutics Heron Therapeutics GAAP EPS of -$0.17 beats by $0.14, revenue of $31.43M misses by $0.4M Seeking Alpha’s Quant Rating on Heron Therapeutics For further details see: Heron Therapeutics says chief development...
News, Short Squeeze, Breakout and More Instantly...
Heron Therapeutics Inc. Company Name:
HRTX Stock Symbol:
NASDAQ Market:
Heron Therapeutics Inc. Website:
Shares of Ionis Pharmaceuticals (NASDAQ: IONS) and Biogen (NASDAQ: BIIB) lost at least 2% in market cap on Thursday after the companies announced t...
2024-05-17 10:45:03 ET Alphabet Inc (GOOGL) GOOGL is trading UP for the last 5 days, and it at trading at $171.27 with volume of 23,281,227 and a one day change of $3.22 (1.91%). Alphabet Inc has a 52-week low of 105.16 and a 52-week high of $174.71. The business's 50-day moving ave...
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates PR Newswire Net Product Sales of $34.7 million , which increased from $29.6 million for the same period in 2023. Net Loss Per Share $(0.02) , which decreased...